- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05151276
Mobile Phone-based Video Education on Diabetes
Effectiveness of Mobile Phone-based Distance Video Education in Individuals With Type 2 Diabetes: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
MATERIALS AND METHODS:
This study is a randomized controlled trial.
Participants:
The population of the study consisted of individuals with type 2 diabetes who presented to hospital diabetes outpatient clinic between July 2018 and January 2019, and the study sample, on the other hand, included a total of 100 individuals with type 2 diabetes who met the inclusion criteria and agreed to participate in the study. The study was completed with a total of 93 subjects, including 46 in the intervention group (n = 46) and 47 in the control group (n= 47). A Diagnosis and Follow-up Form for Individuals with Diabetes (socio-demographic characteristics, diabetes-related characteristics, metabolic values), which was prepared by the researcher in line with the literature, and the Turkish Multidimensional Diabetes Questionnaire (T-MDDQ) were used to collect the data.
Preparation and content of the education material:
The education material was based on four different guidelines, namely, educator's guidelines for adults with diabetes; the diagnosis, treatment, and follow-up guidelines for diabetes mellitus and its complications; diabetes diagnosis and treatment guidelines; and international education guidelines for diabetes health professionals. The diabetes education videos prepared and presented by the researcher in line with these resources were sent to the participants' smartphones in parts. The educational content consisted of 8 sections: what is diabetes? (basic concepts, symptoms, diagnostic criteria, importance), medical nutrition therapy in diabetes, exercise therapy in diabetes, medical treatment in diabetes, acute complications of diabetes, chronic complications of diabetes, foot problems in diabetes, life with diabetes, and diabetes management under special cases.
Data collection process:
The intervention group: In the first meeting, the individuals in the intervention group were informed about the video-based diabetes education and how they would get the videos, and data collection forms were administered. The blood analysis results (HbA1c, glucose, total cholesterol, HDL, LDL, triglyceride) taken on the same day during outpatient clinic follow-ups were recorded. After the administration of the forms, blood pressure, height, and weight measurements were made, and the first interview was completed. Following the first interview, diabetes education videos created previously were sent to the mobile phones of the individuals in two episodes a week fashion. Video submission was completed in a total of four weeks. In the second interview, three months after the video submission had been completed, data collection forms were re-administered to the individuals, and blood analysis results were recorded. The interview was completed after measuring their blood pressure and weight. During the period between the first and second interviews, the individuals continued to receive routine outpatient follow-ups.
The control group: In the first interview, the individuals with diabetes in the control group were given information about the study, and then data collection forms were administered. The blood analysis results (HbA1c, glucose, total cholesterol, HDL, LDL, triglyceride) taken on the same day during outpatient clinic follow-ups were recorded. The first interview was completed after blood pressure, height, and weight measurements were made. Later, individuals continued to receive routine outpatient follow-ups without any other procedures. In the second interview held three months later, data collection forms were re-administered, and blood analysis results, blood pressure, and weight measurements were recorded. At the end of the second interview, diabetes education videos were sent to the individuals in the control group, too, and they were provided with the same education.
Data analysis:
The statistical package for social science (SPSS) version 25.0 (IBM Corp. Armonk, NY) was used to analyze the data. P<.05 was accepted statistically significant. In descriptive statistics, mean, ± standard deviation, median, minimum and maximum values, and percentages were used, and in nonparametric tests, Mann-Whitney U, Pearson's chi-square, Fisher's exact test, McNemar's test, Wilcoxon signed ranks test, and Spearman's rho measurements were employed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Altıeylül
-
Balıkesir, Altıeylül, Turkey, 10100
- Balıkesir University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having a diagnosis of Type 2 diabetes mellitus for at least 6 months.
- Being between the ages of 18-65.
- Being on oral antidiabetic and/or insulin therapy.
- Having a mobile phone capable of receiving and playing video messages.
- Volunteering to participate in the study.
- Sensory losses such as hearing and speech that will prevent communication
Exclusion Criteria:
- Being under 18 years of age
- Not having a mobile phone capable of receiving and playing video messages
- Not willing to participate in the study
- Having sensory loss such as hearing and speaking that prevents communication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention Group
individuals with odd sequence numbers were assigned to the intervention group (n=46)
|
Following the first interview, diabetes education videos created previously were sent to the mobile phones of the individuals in two episodes a week fashion.
Video submission was completed in a total of four weeks.
In the second interview, three months after the video submission had been completed, data collection forms were re-administered to the individuals, and blood analysis results were recorded.
|
|
NO_INTERVENTION: Control Group
those with even numbers to the control group (n=47).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Turkish Multidimensional Diabetes Questionnaire
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
Change from baseline diabetes-related cognitive and social factors at 3 months. Responses were on a Likert-type scale (0-not at all significant). not, 100-very important) is marked. High school scores perceived self-efficacy and outcome indicates high expectations. |
pre-test (baseline), post-test (3 months follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HbA1C
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
HbA1C-change from baseline HbA1C at 3 months
|
pre-test (baseline), post-test (3 months follow-up)
|
|
glucose
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
glucose -change from baseline glucose at 3 months
|
pre-test (baseline), post-test (3 months follow-up)
|
|
total cholesterol
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
total cholesterol -change from baseline total cholesterol at 3 months
|
pre-test (baseline), post-test (3 months follow-up)
|
|
HDL
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
HDL -change from baseline HDL at 3 months
|
pre-test (baseline), post-test (3 months follow-up)
|
|
LDL
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
LDL -change from baseline LDL at 3 months
|
pre-test (baseline), post-test (3 months follow-up)
|
|
triglyceride
Time Frame: pre-test (baseline), post-test (3 months follow-up)
|
triglyceride -change from baseline triglyceride at 3 months
|
pre-test (baseline), post-test (3 months follow-up)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ali Kamil Bayraktar, Balikesir University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BAUN"OTEKİR-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on mobile phone-based distance video education group
-
Suleyman Demirel UniversityNot yet recruitingEducational Interventions | Palpation Skills | Physical Therapy Education | Health Professions Education
-
Obafemi Awolowo UniversityCompleted
-
Penang Hospital, MalaysiaUnknown
-
Zonguldak Bulent Ecevit UniversityActive, not recruitingFebrile ConvulsionTurkey
-
Özlem BEKDEMİR AKIstanbul University - CerrahpasaCompletedBreast Cancer AwarenessTurkey
-
Ataturk UniversityCompletedLife Style, Healthy | Intestinal Stoma Site Hemorrhage | Intestinal Stoma LeakageTurkey (Türkiye)
-
Kırıkkale UniversityCompletedEducation | Nursing Care | Student Nursing | Medical-surgical NursingTurkey
-
University of California, San FranciscoNational Institute of Nursing Research (NINR); American Heart AssociationWithdrawnPhysical Activity | Sedentary LifestyleUnited States
-
Linkoeping UniversityNot yet recruiting
-
Karolinska InstitutetCompleted